← SynDRA
OLCEGEPANT
SynDRA canonical compound SYN0006215 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | CALCA | CALCRL | RAMP1 |
| Mechanism of action | calcitonin antagonist |
All known targets
Mechanisms of action (all sources)
- CALCRL ANTAGONIST
- Calcitonin gene-related peptide type 1 receptor antagonist
- CALCRL MODULATOR
Drug classes
- Calcitonin Gene-Related Peptide Receptor Antagonists
Cross-references
Synonyms
- BIBN-4096 BS
- BIBN-4096BS
- Olcegepant [INN]
- BIBN-4096
- BIBN 4096 BS
- N-((1R)-2-(((1S)-5-Amino-1-((4-(pyridin-4-yl)piperazin-1-yl)carbonyl)pentyl)amino)-1-(3,5-dibromo-4-hydroxybenzyl)-2-oxoethyl)-4-(2-oxo-1,4-dihydroquinazolin-3(2H)-yl)piperidine-1-carboxamide
- N-[(2R)-1-[[(2S)-6-amino-1-oxo-1-(4-pyridin-4-ylpiperazin-1-yl)hexan-2-yl]amino]-3-(3,5-dibromo-4-hydroxyphenyl)-1-oxopropan-2-yl]-4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide
- BIBN 4096BS
- BIBN4096BS
- WOA5J8TX6M
- olcegepantum
- RefChem:168060
- DTXCID0096934
- BIBN 4096
- bibn4096
- UNII-WOA5J8TX6M
- C38H47Br2N9O5
- Olcegepant?
- BIBN-4096;BIBN 4096BS
- OLCEGEPANT [WHO-DD]
- GTPL702
- orb1309304
- SCHEMBL2252127
- SCHEMBL29357241
- GLXC-15723
- BDBM50184069
- EX-A10485
- MFCD07772306
- AKOS024458225
- CS-0360
- EBC-382042
- T12293L
- DA-56412
- HY-10095
- MS-31609
- NS00073138
- (2H)-yl)piperidin-1-yl]carbonyl}-D-tyrosinamide
- BRD-K43927145-001-01-2
- BRD-K43927145-001-02-0
Look up OLCEGEPANT in the interactive SynDRA portal →